I have to wonder if your invested. Do you just feel the
I have to wonder if your invested. Do you just feel the need to bash?
Nobody said Leronlimab is the cure for cancer. The whole idea behind Leronlimab for cancer in my view is we stop metastasis but for how long? The hope is that we can stop it forever but if not. The theory is we can slow or temporarily stop solid tumor cancer long enough or in combination with other cancer treatment or drugs to cure the individual cases we are used for. That is something we are currently seeing in our basket trial and the evidence is building to a long pause in metastasis. We have approached an average of almost a year for terminally ill patients in the basket trial. That extension of life is priceless. Time will tell how long of a pause we can attain. Bashing our ability in cancer with “ c’mon people” is just a plain ignorant statement of someone who either doesn’t pay attention or just wants to bash.
RTB:
When you attack Leronlimab or the company you don’t seem to be a positive investor or an investor at all. If your not a believer and that is your problem. You might want to look for some other investment you can believe in or just do the needed due diligence on this investment. Your whole believe in Leronlimab will change if you put in the time and do the research. We are here because of the immense potential of this molecule.
GLTU and us all.
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Nykredit Invest Balance Lifts Suspension for Investments It is with great news that Nykredit Portefølje Administration A/S has announced the suspension lift for several of its investment funds. Investors looking to engage their resources can now successfully allocate into the specified divisions. This significant step means investors can restart their activities in...
Continue Reading
Chaince Digital Holdings Completes Investment Round Chaince Digital Holdings Inc. (“Chaince” or the “Company”) (Nasdaq: CD), a leading fintech and digital asset-focused firm, has just finalized a private placement with institutional investors. This strategic move has brought in approximately US$6.14 million, underscoring robust investor confidence in the Company's...
Continue Reading
Alpha Modus Completes Merger with Insight Acquisition Corp Alpha Modus Holdings, Inc. is excited to share the successful closure of its business combination with Insight Acquisition Corp. This merger positions Alpha Modus to begin trading its common stock under the ticker symbol "AMOD" on the Nasdaq Global Market. Significance of the Business Combination This strategic...
Continue Reading
Overview of Olympic Steel's Financial Results Olympic Steel (ZEUS), a prominent metals service center, has recently reported its financial performance for the third quarter of 2024. The company achieved a net income of $2.7 million and an impressive earnings before interest, taxes, depreciation, and amortization (EBITDA) of $15 million. While these figures mark a decline...
Continue Reading
Lucid Software Recognized as a Top Innovator for 2025 Lucid Software, a prominent leader in visual collaboration, has been honored by Fast Company as one of the World's Most Innovative Companies for 2025. This acknowledgement emphasizes the company's dedication to revolutionizing team collaboration, enabling organizations to operate more efficiently and effectively....
Continue Reading